Debora S. Bruno, MD | Medical ...

Dr. Debora S. Bruno

Claim this profile

Case Western Reserve University

Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
9 reported clinical trials
19 drugs studied

Area of expertise

1

Lung Cancer

Debora S. Bruno has run 7 trials for Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
HER2 positive
2

Non-Small Cell Lung Cancer

Debora S. Bruno has run 5 trials for Non-Small Cell Lung Cancer. Some of their research focus areas include:

Stage IV
Stage III
EGFR positive

Affiliated Hospitals

Image of trial facility.

Case Western Reserve University

Image of trial facility.

University Hospitals Cleveland Medical Center

Clinical Trials Debora S. Bruno is currently running

Image of trial facility.

Osimertinib + Bevacizumab

for Lung Cancer

This phase III trial compares the effect of bevacizumab and osimertinib combination vs. osimertinib alone for the treatment of non-small cell lung cancer that has spread outside of the lungs (stage IIIB-IV) and has a change (mutation) in a gene called EGFR. The EGFR protein is involved in cell signaling pathways that control cell division and survival. Sometimes, mutations in the EGFR gene cause EGFR proteins to be made in higher than normal amounts on some types of cancer cells. This causes cancer cells to divide more rapidly. Osimertinib may stop the growth of tumor cells by blocking EGFR that is needed for cell growth in this type of cancer. Bevacizumab is in a class of medications called antiangiogenic agents. It works by stopping the formation of blood vessels that bring oxygen and nutrients to tumor. This may slow the growth and spread of tumor. Giving osimertinib with bevacizumab may control cancer for longer and help patients live longer as compared to osimertinib alone.

Recruiting

2 awards

Phase 3

31 criteria

Image of trial facility.

Educational Intervention

for Disparities in Clinical Trial Access

This study focuses on psychosocial barriers at the patient level with the goal of promoting high quality decision making around clinical trials participation. The proposed study adapts the PRE-ACT model to racial and ethnic minority patients who were underrepresented in the original PRE-ACT study and will be combined with a patient navigator model.

Recruiting

1 award

N/A

More about Debora S. Bruno

Clinical Trial Related

5 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 4 Active Clinical Trials

Treatments Debora S. Bruno has experience with

  • Nivolumab
  • Bevacizumab
  • Pembrolizumab
  • Osimertinib
  • Pemetrexed
  • Educational Intervention

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Debora S. Bruno specialize in?

Is Debora S. Bruno currently recruiting for clinical trials?

Are there any treatments that Debora S. Bruno has studied deeply?

What is the best way to schedule an appointment with Debora S. Bruno?

What is the office address of Debora S. Bruno?

Is there any support for travel costs?